Circulating Complement C1q as a Novel Biomarker is Associated with the Occurrence and Development of COPD

PURPOSE: Increasing evidence has shown that the immune response interacts with the chronic inflammatory response and gives rise to the occurrence and development of COPD. Complement component 1q (C1q), as a subcomponent of the C1 complex, could be involved in innate and adaptive immunity. Our study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ke, Han, Kangkang, Liu, Hui, Zheng, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883408/
https://www.ncbi.nlm.nih.gov/pubmed/35237032
http://dx.doi.org/10.2147/COPD.S347607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883408/
https://www.ncbi.nlm.nih.gov/pubmed/35237032
http://dx.doi.org/10.2147/COPD.S347607

Ejemplares similares